Biome Australia Limited (ASX:BIO)
Australia · Delayed Price · Currency is AUD | Market Cap | 51.30M -41.5% |
| Revenue (ttm) | 21.95M +38.4% |
| Net Income | 957.91K +231.9% |
| EPS | 0.00 +228.2% |
| Shares Out | 228.00M |
| PE Ratio | 51.70 |
| Forward PE | 15.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 595,327 |
| Open | 0.2150 |
| Previous Close | 0.2250 |
| Day's Range | 0.2000 - 0.2250 |
| 52-Week Range | 0.2050 - 0.6300 |
| Beta | 1.02 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 29, 2026 |
About Biome Australia
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Aus... [Read more]
Financial Performance
Financial StatementsNews
Biome Australia Earnings release: Q3 2026
Biome Australia released its Q3 2026 earnings on April 28, 2026, summarizing the period's financial results.
Biome Australia Earnings Call Transcript: H1 2026
Record H1 2026 revenue and profit growth driven by premium practitioner-only model, strong gross margins, and expanding distribution. International expansion and proprietary clinical pipeline support long-term growth, with disciplined capital management and no retail price increases since 2019.
Biome Australia Quarterly report: H1 2026
Biome Australia has published its H1 2026 quarterly earnings report on February 24, 2026.
Biome Australia Slides: H1 2026
Biome Australia has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 24, 2026.
Biome Australia Earnings release: H1 2026
Biome Australia released its H1 2026 earnings on February 24, 2026, summarizing the period's financial results.
Biome Australia Earnings release: Q2 2026
Biome Australia released its Q2 2026 earnings on January 27, 2026, summarizing the period's financial results.
Biome Australia Transcript: AGM 2025
Record attendance marked a year of strong growth, with sales up 41% and net profit achieved. Key resolutions on remuneration, director re-election, share issues, and expansion plans were passed. International growth and new product launches position the company for continued success.
Biome Australia Earnings Call Transcript: Q1 2026
Record Q1 FY 2026 with $24M annualized sales, $462K EBITDA, and 84% YoY cash receipts growth. International expansion in Canada, Ireland, and New Zealand is accelerating, while gross margin remains above 61% and new product launches drive further growth.
Biome Australia Earnings release: Q1 2026
Biome Australia released its Q1 2026 earnings on October 22, 2025, summarizing the period's financial results.
Biome Australia Annual report: H2 2025
Biome Australia has published its H2 2025 annual report on August 27, 2025.
Biome Australia Earnings release: H2 2025
Biome Australia released its H2 2025 earnings on August 27, 2025, summarizing the period's financial results.
Biome Australia Transcript: Investor Update
FY 2025 saw record revenue, strong EBITDA, and rapid distribution growth, with new product launches and international expansion driving performance. Vision 2027 targets remain on track, supported by innovation, premium positioning, and scalable global strategy.
Biome Australia Earnings release: Q4 2025
Biome Australia released its Q4 2025 earnings on July 29, 2025, summarizing the period's financial results.
Biome Australia Transcript: Status Update
Record growth and profitability are expected for FY25, with product innovation and international expansion driving momentum. Manufacturing flexibility and a growing institutional investor base support long-term strategic goals.